On December 17, 2019, Pomerantz LLP was appointed Lead Counsel in a securities litigation class action against Sarepta Therapeutics, Inc. and certain of its senior officers for violation of the federal securities laws.
Back to Pomerantz News
On December 17, 2019, Pomerantz LLP was appointed Lead Counsel in a securities litigation class action against Sarepta Therapeutics, Inc. and certain of its senior officers for violation of the federal securities laws.